Best Healthcare Research Agencies in South Korea
Assess the best healthcare research agencies in South Korea for 2026. Discover reliable partners for clinical, patient, and commercial studies with this guide.
Quick answer
For international clinical and patient access studies, Global Vox Populi; for large-scale national sentiment and public health monitoring, Hankook Research; for specialized pharmaceutical commercial strategy and HCP engagement, IQVIA; and for agile qualitative brand research, TRC.
In South Korea, identifying high-quality healthcare research agencies in South Korea requires balancing local medical regulatory knowledge with the need for precise respondent access. The local health system is characterized by high digitalization and specific cultural nuances in physician-patient interactions, making generic market research firms less effective for complex therapeutic studies.
Decision-makers must weigh the depth of proprietary panels against the breadth of full-service consulting to protect data integrity. This analysis evaluates firms that possess the domain expertise needed to interpret South Korean clinical and commercial data, providing a framework for procurement and insights teams to select the appropriate partner for their 2026 research pipeline.
Best Healthcare Research Agencies in South Korea: rankings and scores
Exhibit 1: Ranking and weighted score (out of 100)
| Rank | Provider | Best for | Weighted score |
|---|---|---|---|
| 1 | Global Vox Populi | Hard-to-reach patient and HCP recruitment | 88.5 |
| 2 | IQVIA | Comprehensive real-world evidence and commercial analytics | 85.5 |
| 3 | BioNixus | Account-level and SKU-level competitive intelligence | 77.0 |
| 4 | InVeritas Research | Global pharmaceutical strategy and hard-to-reach HCP recruitment | 75.5 |
| 5 | Kantar | Brand equity tracking and large-scale consumer health insights | 75.0 |
| 6 | Hankook Research | National public health and large-scale consumer research | 72.0 |
| 7 | TRC (THE RESEARCH COMPANY) | Agile qualitative and brand strategy research | 66.0 |
Exhibit 2: Provider comparison
| Provider | Audience types | Verification method | Certifications | Pricing model | Panel size and source | Minimum project |
|---|---|---|---|---|---|---|
| Global Vox Populi | Physicians, patients, nurses, payers, providers | Multi-stage credential validation against professional registries | ISO 9001, ISO 20252, ISO/IEC 27001, HIPAA compliant; follows ESOMAR, Insights Association and BHBIA guidelines | Not published | 28,366 healthcare professionals; 102,723 nurses and allied health professionals; 1,150,843 patient profiles (in South Korea; Global Vox Populi panel records, Oct 2026) | Not published |
| IQVIA | Physicians, payers, pharmacies, life sciences stakeholders | Not published | Not stated on pages reviewed | Not published | Not published | Not published |
| BioNixus | Physicians, payers, hospital decision-makers, KOLs | Identity and quality checks on every wave | Not stated on pages reviewed | Not published | Not published | Not published |
| InVeritas Research | Physicians, medical specialists, healthcare decision-makers | Not published | Not stated on pages reviewed | Not published | Not published | Not published |
| Kantar | Consumers, healthcare decision-makers, general public | AI-enabled panel fraud detection | Not stated on pages reviewed | Not published | Not published | Not published |
| Hankook Research | Physicians, pharmacists, patients, general public | Not published | Not stated on pages reviewed | Not published | Not published | Not published |
| TRC (THE RESEARCH COMPANY) | Consumers, healthcare professionals, B2B decision-makers | Not published | Not stated on pages reviewed | Not published | Not published | Not published |
Exhibit 3: Capability matrix
| Provider | Quantitative | Qualitative | Own panels / sample | Healthcare | B2B | Multi-country |
|---|---|---|---|---|---|---|
| Global Vox Populi | ● | ● | ● | ● | ● | ● |
| IQVIA | ● | – | – | ● | – | – |
| BioNixus | ● | ● | – | ● | – | – |
| InVeritas Research | ● | ● | – | ● | ● | – |
| Kantar | ● | ● | ● | ● | – | ● |
| Hankook Research | ● | ● | ● | ● | – | – |
| TRC (THE RESEARCH COMPANY) | ● | ● | – | ● | ● | – |
Table data from each provider’s own website and public sources, reviewed October 2026. “Not published” means the provider does not state it publicly. ● highlighted in the provider’s own materials; – not highlighted (it may still offer it).
How we scored these providers
Score providers based on their ability to combine medical domain expertise with rigorous data validation protocols.
| Criterion | Weight | What it means here |
|---|---|---|
| Industry Expertise | 20 | This measures the depth of understanding regarding the South Korean healthcare system, including HIRA and NHIS processes. High scores go to firms that demonstrate specific knowledge of local treatment guidelines, regulatory hurdles for medical devices, and the nuances of the physician-patient relationship within the national health system. |
| Compliance, Certifications and Security | 20 | This evaluates the agency's adherence to global standards like ISO 20252 and local data protection regulations. For healthcare research, it includes HIPAA-aligned processes and strict adverse event reporting procedures. Providers must show they can handle sensitive health data with enterprise-grade security and maintain ethical research practices. |
| Target Audience Reach | 15 | This assesses the ability to access specific HCP specialties and patient cohorts. A top-performing firm provides deep profiling for low-incidence conditions and maintains verified, active panels of surgeons, nurses, and payers. It requires a documented process for recruiting and re-validating professional credentials to protect panel quality. |
| Research Quality | 10 | This examines the rigor applied to study design, questionnaire logic, and sampling techniques. It focuses on how the provider prevents fraud, straight-lining, and bot activity. Good results are driven by multi-layered quality checks, including identity verification and response consistency analysis, making sure that findings are statistically sound and reliable. |
| Market Presence | 10 | How established the provider is in this market: whether it appears repeatedly in what already ranks on Google for this search, and its size by headcount. Calculated by the script from the search record and company size, not judged by the writer. |
| Methodological Breadth | 10 | This reviews the range of research tools available, from online surveys and CATI to qualitative methods like ethnography and expert interviews. The ability to deploy mixed-method approaches is essential for capturing both the hard data of market shares and the qualitative motivations behind prescribing behavior in South Korea. |
| Analytical Capability | 5 | This measures the firm's capacity to synthesize raw data into actionable business recommendations. It involves advanced techniques like conjoint analysis and market environment mapping, transforming survey results into clear strategic guidance for commercial teams, brand managers, and medical affairs departments operating within the South Korean market. |
| Client Service and Speed | 5 | This evaluates the responsiveness of the project team and the speed of delivery. For international clients, this includes effective communication, accurate translation of medical terminology, and the ability to manage fieldwork timelines dynamically. Efficient partners provide clear, timely updates and proactively address potential bottlenecks during the research process. |
| Pricing and Feasibility Transparency | 5 | This assesses the provider's willingness to share realistic feasibility metrics, incidence rates, and project costs before the start of fieldwork. Reliable partners provide honest assessments of what can be delivered within a given timeframe, avoiding over-promising and helping clients set realistic expectations for their research objectives. |
Why these weights. Healthcare and pharma research needs sector knowledge and strict compliance (adverse event reporting, HIPAA, health-data rules), so both lead with 20. Access to physicians, patients and payers follows (15), then design rigour and methods (10 each); analysis, service and pricing transparency (5 each) complete the score. Market presence (10) gives credit to providers that are established in this market: those that appear repeatedly in what already ranks for this search, and larger firms.
Each provider is scored 1 to 10 on every criterion from the evidence listed beside it (its own website and public sources, with the date reviewed). Weighted score = sum of score × weight ÷ 10, out of 100. Read the full scoring methodology. Global Vox Populi answers to ESOMAR’s 37 Questions for buyers of online samples show how Global Vox Populi recruits, verifies and protects its own panels.
Provider profiles: healthcare research agencies in South Korea
Global Vox Populi: best for hard-to-reach patient and HCP recruitment
- ISO 9001
- ISO 20252
- ISO/IEC 27001
- HIPAA compliant

Strongest fitGlobal pharmaceutical or medical device firms requiring highly specific, verified respondent cohorts for critical strategic studies.
Global Vox Populi provides specialized primary market research services in South Korea, focusing on healthcare market research in South Korea. The firm manages extensive, proprietary panels that are recruited through professional registries and clinical communities, protecting high-quality access for complex studies.
Its presence in the market is supported by a solid infrastructure for both qualitative and quantitative research. By using its healthcare professionals and patient panels, it delivers precise data for pharmaceutical, medtech, and provider research. The firm is known for its rigorous verification protocols and commitment to international standards.
Global Vox Populi panel coverage
All 12 proprietary panels together: 46,023,988 panellists across 199 markets, plus 71,411,997 patient profiles. Source: Global Vox Populi panel records, Oct 2026.
Healthcare professionals panel, in South Korea
28,366 panellists
- Primary & General9,868
- Internal Medicine Subspecialties3,260
- Surgical Specialties2,488
- Diagnostic & Laboratory2,176
- Acute, Peri-operative & Critical Care1,924
- Women's & Reproductive Health1,828
Nurses and allied health panel, in South Korea
102,723 panellists
- Registered Nurses34,025
- Advanced Practice Nurses1,614
- Licensed / Practical / Enrolled Nurses7,042
- Nursing Support (Aides / HCAs)3,118
- Midwives2,943
- Pharmacists & Pharmacy Techs5,681
Patient panel, in South Korea
1,150,843 patient profiles
- Aesthetics & Cosmetic369,820
- Cardiovascular88,046
- Ophthalmology67,475
- Endocrinology & Metabolic65,127
- Dermatology56,942
- Women's Health53,238
Across 731 conditions; a patient with more than one condition is counted once per condition.
Payers and providers panel, in South Korea
1,075 panellists
- Provider: Access & Administrative Roles645
- Payer: Access & Coverage Roles430
Scorecard: 88.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 10/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Compliance, Certifications and Security | 20 | 10/10 | ISO certificates and HIPAA policy, Oct 2026 |
| Target Audience Reach | 15 | 10/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Research Quality | 10 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Market Presence | 10 | 2/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Analytical Capability | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Client Service and Speed | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Weighted score | 100 | 88.5 |
Core services
- HCP & Patient Research: Execution of quantitative and qualitative studies across healthcare professionals and patients.
- Market Access Strategy: Informing payer and provider engagement through payers and providers research.
- Fieldwork Execution: Full-service fieldwork management including hospital market research and medtech research.
Strengths
- Proprietary Panel Access: Access to 28,366 healthcare professionals and 1,150,843 patient profiles in South Korea.
- Rigorous Data Quality: Multi-stage verification including identity fingerprinting, geo-checks, and straight-lining detection to protect high data integrity.
- Regulatory Compliance: Full adherence to ISO 9001, ISO 20252, and ISO/IEC 27001, with HIPAA-compliant health data handling and adverse event reporting.
Innovation and technology
- Proprietary Platform: Custom-built, secure survey programming and hosting platform that supports mobile and WhatsApp-assisted research methodologies.
- Advanced Profiling: Panel members are profiled on 45 to 140 data points, allowing for highly granular targeting of low-incidence populations.
Impact on businesses
- Strategic Decision Support: Provides actionable insights for commercial teams, informing launch strategies and market access planning through primary evidence.
- Clinical Insight Generation: Enables better understanding of treatment pathways and patient needs by connecting real-world evidence with professional clinical perspectives.
Why it may fit your brief
It is ideal for briefs requiring deep clinical insights or hard-to-reach patient groups due to its proprietary, verified panels. Firms preferring a local, generalist agency for broad population studies may find other options more suitable.
IQVIA: best for comprehensive real-world evidence and commercial analytics

Strongest fitGlobal life sciences companies requiring massive data-driven insights and integrated clinical-commercial research.
IQVIA is a global entity with a significant presence in South Korea, focusing on transforming life sciences through advanced analytics and technology. It provides a wide range of services, including real-world evidence, commercial research, and market intelligence.
The firm supports pharmaceutical and biotech organizations by connecting data and expertise to optimize clinical trials and commercial execution. Its ability to provide end-to-end solutions makes it a key partner for complex, data-heavy healthcare research projects.
Scorecard: 85.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 10/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 85.5 |
Core services
- Commercial Intelligence: Provides market environment analysis, share-of-wallet tracking, and benchmarking services.
- Real-World Evidence: Generates clinical evidence to demonstrate value and support market access strategies.
- Clinical Development: Offers full-service clinical trial solutions with specialized teams and predictive analytics.
Strengths
- Data-Driven Insights: Uses vast proprietary datasets to provide accurate market intelligence and predictive modeling.
- Full-Service Capability: Combines clinical development with commercial execution to support the entire lifecycle of a medical asset.
Innovation and technology
- IQVIA.ai Platform: Uses AI-driven platforms for predictive clinical development and commercial agentic analytics.
Impact on businesses
- Asset Maximization: Helps organizations increase the probability of success for their assets through integrated intelligence.
Why it may fit your brief
Its data depth is extensive for large commercial projects. Small-scale or highly agile qualitative studies may be more cost-effectively handled by smaller, dedicated boutique research firms.
BioNixus: best for account-level and SKU-level competitive intelligence

Strongest fitPharmaceutical commercial teams needing specific competitive intelligence at the account or hospital level.
BioNixus provides primary market research designed to deliver account-level and SKU-level brand data. It operates with a strong focus on the healthcare and pharmaceutical sectors, helping commercial teams move beyond national averages to understand specific hospital and department dynamics.
The firm uses local teams to conduct interviews, surveys, and mystery shops, protecting high-quality primary research. Its approach is geared toward providing actionable decision packs that commercial directors can use to inform launch planning and share strategies.
Scorecard: 77.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 9/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 8/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 77.0 |
Core services
- Account-Level Research: Delivers granular brand versus competitor data at the hospital and SKU level.
- Physician Surveys: Conducts statistically solid surveys across physician specialties using conjoint and MaxDiff methodologies.
- Market Access Insights: Provides payer environment analysis, pricing, and HTA dossier support for market access teams.
Strengths
- Granular Data Depth: Specializes in breakdowns that traditional syndicated feeds miss, such as sub-accounts and traditional trade.
- Fast Turnaround: Offers proposals within 48 hours of brief, supporting rapid response to commercial needs.
Innovation and technology
- Decision-Centric Design: Scopes research directly around the commercial decision rather than using template-based approaches.
Impact on businesses
- Launch Optimization: Provides the granular intelligence needed to change launch or share plans in specific countries and accounts.
Why it may fit your brief
Its focus on granular, account-level data is highly effective for launch strategy. It is less suited for general population sentiment studies compared to larger, multi-purpose research firms.
InVeritas Research: best for global pharmaceutical strategy and hard-to-reach HCP recruitment

Strongest fitGlobal pharmaceutical firms requiring high-quality, specialized HCP recruitment for targeted commercial research.
InVeritas Research operates a dedicated research team in South Korea, offering a full range of quantitative and qualitative market research services. The firm is known for its expertise in reaching difficult-to-access audiences, including medical sub-specialties like transplant surgeons and pediatric-oncologists.
The firm emphasizes high-quality project execution, using strict quality control standard operating procedures. By partnering with global pharmaceutical and healthcare clients, it provides actionable data that supports commercial strategy and brand leadership in local target markets.
Scorecard: 75.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | inveritasresearch.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | inveritasresearch.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | inveritasresearch.com (6 pages reviewed), Oct 2026 |
| Research Quality | 10 | 7/10 | inveritasresearch.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 7/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | inveritasresearch.com (6 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 7/10 | inveritasresearch.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 6/10 | inveritasresearch.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | inveritasresearch.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 75.5 |
Core services
- Healthcare Research: Delivers full-service quantitative and qualitative research for the pharmaceutical and medical device sectors.
- Qualitative Services: Conducts in-depth interviews, focus groups, and usability testing with specialized medical professionals.
- B2B Market Intelligence: Provides tailored market research for banking, finance, and healthcare industries.
Strengths
- Specialized Recruitment: Proven capability in recruiting hard-to-reach audiences such as senior medical specialists and decision-makers.
- Quality Control: Follows rigorous quality control SOPs, with all deliverables checked by dedicated teams and project directors.
Innovation and technology
- Bespoke Research Design: Tailors methodologies for each project, making sure that research tools fit the unique needs of the medical brand.
Impact on businesses
- Data-Driven Decisions: Enables stakeholders with real-world data to take commercially sound decisions in the healthcare market.
Why it may fit your brief
Its focus on difficult-to-reach experts makes it a strong partner for complex pharma briefs. Clients looking for highly automated, low-cost general population studies might explore other options.
Kantar: best for brand equity tracking and large-scale consumer health insights

Strongest fitHealthcare brands focused on consumer-facing marketing and long-term brand equity development.
Kantar is a global research and consulting firm with an established office in South Korea. It offers comprehensive data and insights to support brand growth, product development, and customer understanding in the healthcare and consumer health sectors.
The firm uses proprietary panels and advanced AI-enabled quality assurance to provide reliable survey results. Its frameworks for brand valuation and consumer journey mapping help healthcare clients make informed strategic decisions based on solid data.
Scorecard: 75.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 75.0 |
Core services
- Brand Research: Provides brand health tracking, equity studies, and valuation for healthcare and consumer brands.
- Consumer Insights: Analyzes consumer behavior and decision-making processes to guide marketing and product strategy.
- Survey Solutions: Offers agile, templated survey solutions for rapid market understanding and brand lift measurement.
Strengths
- Global Panel Reach: Access to millions of panelists across global markets with solid sampling and blending technologies.
- Advanced Quality Tech: Uses Qubed AI and deep neural networks to detect and prevent fraud in real time.
Innovation and technology
- Kantar Marketplace: An agile research platform that combines fast survey delivery with deep analytical expertise.
Impact on businesses
- Brand Growth: Turns human understanding into meaningful business outcomes to drive brand saliency and preference.
Why it may fit your brief
Its strength in consumer brand research is excellent for OTC or consumer health portfolios. It may be less specialized in deep clinical pathway research compared to firms focused strictly on the physician-payer network.
Hankook Research: best for national public health and large-scale consumer research

Strongest fitLarge organizations seeking extensive, representative data for national-level healthcare policy or public health research in South Korea.
Hankook Research is one of the largest market research firms in South Korea, possessing 48 years of industry experience. Its dedicated Healthcare Research Division provides comprehensive services for hospitals, medical device companies, and pharmaceutical firms, using deep local industry knowledge.
The firm maintains extensive domestic panels, which allow for large-scale quantitative studies and patient experience measurement. Its infrastructure supports a wide array of research methodologies, making it a reliable partner for studies requiring broad representative samples across the South Korean population.
Scorecard: 72.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | hrc.co.kr (2 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | hrc.co.kr (2 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | hrc.co.kr (2 pages reviewed), Oct 2026 |
| Research Quality | 10 | 7/10 | hrc.co.kr (2 pages reviewed), Oct 2026 |
| Market Presence | 10 | 7/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | hrc.co.kr (2 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 6/10 | hrc.co.kr (2 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | hrc.co.kr (2 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | hrc.co.kr (2 pages reviewed), Oct 2026 |
| Weighted score | 100 | 72.0 |
Core services
- Healthcare Surveys: Conducts physician and pharmacist panel surveys for market understanding and product development.
- Patient Experience: Specializes in patient satisfaction measurement and healthcare service experience studies for hospitals.
- Medical Device Research: Provides specialized research for the medical device industry, including product testing and market analysis.
Strengths
- Local Market Depth: Deep understanding of the South Korean regulatory environment and local healthcare industry dynamics.
- Large Panel Infrastructure: Uses extensive local panels to provide statistically significant data for national healthcare studies.
Innovation and technology
- Advanced Observation Tools: Incorporates VR simulators and remote monitoring equipment to enhance observational research quality.
Impact on businesses
- Strategic Insights: Assists organizations in forming marketing strategies based on verified public opinion and clinical data.
Why it may fit your brief
Its size and history make it suitable for large-scale studies requiring broad reach. It may be less focused on niche, small-sample expert interviews compared to specialized boutique firms.
TRC (THE RESEARCH COMPANY): best for agile qualitative and brand strategy research

Strongest fitBrands looking for deep qualitative understanding of the South Korean market and strategic marketing consulting.
TRC is a full-service marketing research firm in South Korea that offers both qualitative and quantitative research services. Led by industry veterans, the firm provides strategic insights to domestic and international clients, with a focus on understanding consumer and professional behavior.
The agency is well-regarded for its qualitative research capabilities, including in-depth interviews and focus groups. By using modern research techniques and a deep understanding of the local market, TRC delivers actionable findings for brand and product development.
Scorecard: 66.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 7/10 | trcompany.co.kr (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 6/10 | trcompany.co.kr (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 6/10 | trcompany.co.kr (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 7/10 | trcompany.co.kr (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | trcompany.co.kr (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 7/10 | trcompany.co.kr (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | trcompany.co.kr (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | trcompany.co.kr (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 66.0 |
Core services
- Market Research Consulting: Offers consulting on research system development, KPI setting, and customer experience management.
- Qualitative Research: Conducts professional moderated sessions including IDIs, FGDs, and ethnographic studies.
- Quantitative Studies: Executes structured surveys, including online, mobile, and CLT methods for market assessment.
Strengths
- Experienced Leadership: Managed by researchers with extensive experience in the South Korean market and professional marketing education.
- Qualitative Expertise: Strong focus on uncovering deep customer insights through professional moderation and interaction.
Innovation and technology
- Modern Research Techniques: Adopts advanced techniques like JTBD interviews and cognitive interviewing to capture nuanced feedback.
Impact on businesses
- Strategic Marketing Guidance: Helps clients derive foundational data for marketing strategy and brand positioning.
Why it may fit your brief
Its strength in qualitative moderation makes it excellent for exploratory research. It may be less suited for studies requiring massive, automated quantitative panels compared to larger global firms.
How HCP and patient verification actually works in South Korea
Make sure every respondent is verified against national medical registries to maintain data integrity.
Professional Credential Check
For healthcare research, providers must verify the medical licenses and registration status of all HCP participants. This involves cross-referencing respondent details against official government or professional association databases. Ask the agency for their specific protocol for this check and how often they re-validate the credentials of their panel members. A lack of this verification leads to significant risks of data contamination by non-qualified individuals, compromising the validity of findings.
Identity and Geo-Validation
Quality providers use device fingerprinting and geo-location checks to make sure that the respondent is who they claim to be and is located in the target market. This prevents fraud from bots or respondents using VPNs to access surveys from different regions. Request evidence of their anti-fraud technology and how they handle detected anomalies during the screening phase of your research project.
Response Quality Scoring
Agencies should implement rigorous quality checks, including trap questions and straight-lining detection, to filter out low-effort responses. These metrics should be transparently reported in the final data delivery. If a provider cannot explain their method for identifying and removing fraudulent completes, the reliability of their insights remains questionable.
Consent and Compliance
Make sure that the agency follows double opt-in membership and maintains granular, revocable consent from all participants. This is particularly essential when dealing with sensitive health information. Ask for documentation of how they manage participant data under local privacy laws and international research codes, making sure that all interactions are ethical and compliant.
How to choose the right provider in South Korea
Select a partner based on the specific methodological and respondent needs of your study.
- Define Research Scope: Clearly identify whether your study requires deep clinical expertise or broad market sentiment. This determines if you need a specialized boutique firm or a large-scale data provider.
- Evaluate Panel Ownership: Prioritize firms that own their panels. This protects higher control over respondent quality and better profiling for specific therapeutic areas.
- Request Feasibility Proof: Ask for a sample plan that demonstrates the provider can meet your required N-size for the specific sub-specialty or patient condition needed.
- Review Data Integrity: Examine the agency's anti-fraud and verification protocols in detail. A provider that cannot detail its validation process is a significant risk.
- Assess Local Knowledge: For South Korea, make sure the agency understands the local health system, including HIRA and NHIS dynamics. This is key for translating data into actionable local strategy.
Questions to ask before you commission
- How do you verify the clinical credentials of your physician panel members in South Korea?
- Can you provide a breakdown of your panel size by the specific medical sub-specialty required for this study?
- What specific anti-fraud and data quality measures are applied to this project?
- How do you handle adverse event reporting in accordance with local and international regulations?
- What is your typical turnaround time for recruiting and completing a study of this size and complexity?
- How does your team make sure that the translated questionnaire maintains clinical accuracy and cultural relevance?
Common pitfalls to avoid
- Ignoring Panel Sourcing: Relying on agencies that rent panels from unverified third-party sources often leads to poor data quality and high rates of fraudulent responses.
- Overlooking Regulatory Nuance: Assuming a global agency can automatically apply its standard methods to the South Korean healthcare system without local adaptation is a common error.
- Inadequate Feasibility Planning: Failing to demand a detailed feasibility report before starting fieldwork often results in missed deadlines and insufficient sample sizes for niche audiences.
- Misinterpreting Data Depth: Using national-level syndicated data to make account-specific commercial decisions can lead to flawed strategies that fail to reflect local market realities.
What a feasibility check should include
Demand a project-specific feasibility study that explicitly confirms the availability of your target audience.
Respondent Availability
The check must confirm the exact number of active, verified HCPs in the required specialty within the South Korean database. This avoids mid-project delays caused by low incidence.
Incidence Rate Estimation
A reliable feasibility report provides a realistic estimate of the incidence rate for the target patient population. This is necessary for budgeting and setting accurate project timelines.
Credential Verification Timeline
The plan should detail the time required to re-verify professional licenses for the specific respondent group. This makes sure that the study remains compliant with internal quality standards.
Methodological Suitability
The provider must confirm that the chosen method, such as CATI or online survey, is the most effective way to reach the specific group in the local market.
Conclusion
Choosing the right partner from among the available healthcare research agencies in South Korea requires a disciplined approach to procurement. For complex clinical studies and hard-to-reach patient cohorts, firms with proprietary, verified panels, such as Global Vox Populi, offer the highest level of data integrity and targeting precision. For larger national public health sentiment or general consumer health tracking, organizations like Hankook Research provide the necessary scale and local infrastructure.
Use the provided scorecard to align your specific research needs with the core strengths of each agency. Always demand clear evidence of credential verification and data quality protocols before finalizing your shortlist. By focusing on firms that demonstrate both deep clinical domain expertise and a transparent approach to feasibility, you can make sure that your 2026 research pipeline delivers the actionable insights needed to drive commercial and clinical success in the South Korean market.
Planning research in South Korea? Tell us your audience, markets and timeline, and we will come back with a feasibility check and recommended approach.
Frequently asked questions
What are the top healthcare market research agencies in South Korea?
The top agencies depend on the research objective. For specialized clinical and patient access, Global Vox Populi is highly effective. For large-scale national sentiment and public health tracking, Hankook Research is a key provider. For commercial pharmaceutical strategy and data-heavy analytics, IQVIA is a major player, while TRC offers agile qualitative brand strategy.
How do I find a reliable healthcare research partner in Seoul?
Look for firms that demonstrate deep knowledge of the South Korean healthcare system and regulatory environment. A reliable partner will provide transparent feasibility reports, verified respondent credentials, and evidence of compliance with both local and international data protection laws. Always ask for their specific protocols regarding panel recruitment and quality assurance.
Does Hankook Research provide healthcare market research services?
Yes, Hankook Research maintains a dedicated Healthcare Research Division. It provides a range of quantitative and qualitative services, including physician and pharmacist panel surveys, medical device research, and patient experience studies, using its extensive domestic panel and deep local industry knowledge.
What is the role of market research agencies in the South Korean pharmaceutical industry?
These agencies act as critical intermediaries that provide commercial and clinical intelligence. They help pharmaceutical companies understand prescribing behaviors, market access dynamics, competitor environments, and patient needs. By providing evidence-based insights, they support decision-making for product launches, market positioning, and medical affairs strategy within the highly specific South Korean healthcare context.
Are there specialized healthcare research firms for HCP surveys in South Korea?
Yes, several firms specialize in HCP surveys. Global Vox Populi offers proprietary panels of physicians and allied health professionals. BioNixus focuses on granular account-level intelligence and physician surveys for pharma, while InVeritas Research is known for its ability to recruit hard-to-reach medical sub-specialists in the South Korean market.
Which global market research firms have healthcare divisions in South Korea?
Several global firms operate in South Korea with dedicated healthcare divisions. IQVIA provides extensive commercial and clinical data analytics. Kantar uses its global brand research frameworks to support consumer health and pharmaceutical brands. InVeritas Research also maintains a dedicated team for full-service healthcare research in the country.
How can I protect the quality of healthcare research in South Korea?
Protect quality by mandating strict respondent verification against medical registries, using anti-fraud technology like device fingerprinting, and requiring transparent reporting on data cleaning protocols. Partnering with agencies that own their proprietary panels rather than renting from third-party sources significantly reduces the risk of low-quality or fraudulent data in your final research findings.
What is the importance of local panel ownership in South Korean healthcare research?
Panel ownership allows an agency to maintain deep, verified profiles of niche medical professionals and patients. This protects better targeting for low-incidence studies, higher respondent engagement, and more consistent data quality compared to agencies that rely on open-internet survey samples, which often lack the necessary clinical verification for reliable healthcare insights.